Metastasis of Residive Mucinous Ovarian Carcinoma to Umbilicus, Peritoneum, And Ascites Fluid With No Malignancy Marker Found in The Previous Post-Operative Histopathological Examination

Authors

  • Arif Fadillah Resident of Obstetrics and Gynecology, Faculty of Medicine, Andalas University, Dr. M. Djamil Central General Hospital Padang
  • Andi Friadi Sub Division of Gynecological Oncology, Obstetrics and Gynecology Department, Faculty of Medicine, Andalas University, Dr. M. Djamil Central General Hospital Padang

DOI:

https://doi.org/10.25077/aoj.3.2.130-136.2019

Abstract

Background : Malignant ovarian tumor are still the number one cause of death and the second most  of incidents for gynecological malignant tumors. The principles of management of ovarian cancer are the same as the principles of handling other malignant diseases, for the treatment of primary lesions operatively and the handling of potential sites of tumor metastases with chemotherapy. Histopathological examination is still considered a gold standard for diagnosis and definitive treatment of malignant ovarian tumors. If histopathologic results are obtained, then the patient will be planned to undergo postoperative chemotherapy. The mismatch between the preoperative and intraoperative clinical features, and the results of postoperative histopathological examination is a problem in managing cases of ovarian malignant tumors.

Objective : Report a case of residive ovarian carcinoma with no appearance of malignancy marker in the previous postoperative histopathological examination.

Method : Case report

Case : We report the case of a 45-year-old woman with a history of two previous laparotomy. The first operation was carried out in February 2014 on the indication of an extra ovarian cyst, resulting in the impression of a "Follicular Cysts" based on histopathological examination. The second operation was performed in March 2015, performed surgical staging tumors with an indication of malignant ovarian tumors with clinical metastases, but from histopathological examination it was found that "Cystadenoma Ovarii Muscinosum Multiloculare" and "no visible signs of malignancy", so the patient was not managed with postoperative chemotherapy. In April 2019 patients came with complaints of new mass growth, from CT-Scan and USG investigations there was a suspicious impression of a residive ovarian tumor with metastases into the omentum and massive ascites. On May 16, 2019 an optimal debulking was performed with the findings of residive mass, ascites, and mass metastases in the intra operative peritoneum. From the results of histopathological examination, it was found that "Muscinous Carcinoma with metastases to the umbilicus, peritoneum, and ascitic fluid

Keywords: Malignant residive ovarian tumor, mucinous ovarian carcinoma

References

Busmar, B. Kanker Ovarium. Dalam Buku Acuan Nasional Onkologi Ginekologi. Editor: M.F. Azis, Andrijono, dan A.B. Saifuddin. Jakarta:Yayasan Bina Pustaka Sarwono Prawirohardjo, 2010: 524-468.

Prawirohardjo, S. Ilmu Kandungan. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohardjo. 2014.

De Jong, W. Tumor Ovarium dalam Buku Ajar Ilmu Bedah 4th ed. Jakarta: EGC. 2014: 730- 729.

Kumar V, Cotran RS, and Robbins SL. Robbins Basic Pathology 8th ed. New York: W.B. Saunders Company. 2007.

Cuningham, F.G., et al. (2018) Williams Obstetrics, 25th ed, United States: The McGraw-Hill.

Tantri,H. Penilaian Akurasi Diagnosis Potong Beku Pada Tumor Ovarium Jenis Epitel di Departemen Patologi Anatomi RSCM 2009-2011. Jakarta : Majalah Patologi. 2012. Vol 21: 43-37.

Doubeni CA, Doubeni ARB, Myers AE. Diagnosis and Management of Ovarian Cancer. Perelman School of Medicine, University of Pennsylvania. American Academy of Family Physicians 2016. vol 93: 937-44

Burges A, Schmalfteldt B. Ovarian Cancer: Diagnosis and Treatment. Dtsch Arztebl Int 2011; 108(38): 635-41

27th FIGO annual report on the result of treatment in gynecology cancer. Int. J Gynecol Obstet. 2006.

Callahan TL, Caughey AB. Blueprints Obstetrics & Gynecology ed 7th: Philadelphia. Wolters Kluwer, 2018; hal. 1024-44

Panduan Praktik Klinik Kanker Ovarium RSUPN Cipto Mangunkusumo, Jakarta : 2017.

Panduan Praktik Klinik Tumor Ovarium RSUP DR.M.Djamil, Padang : 2018.

Downloads

Published

2019-12-12

Issue

Vol. 3 No. 2 (2019)

Section

CASE REPORT

License

Copyright (c) 2019 JOURNAL OBGIN EMAS

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright

Authors who publish with this journal agree to the following terms:

  1. Authors retain the copyright of published articles and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

License:

Andalas Obstetrics and Gynecology Journal (AOJ) is published under the terms of the Creative Commons Attribution 4.0 International License. This license permits anyone to copy and redistribute this material in any form or format, compose, modify, and make derivatives of this material for any purpose, including commercial purposes, as long as they credit the author for the original work.